Eli Lilly announced on Friday safety and efficacy results from two separate late-stage studies testing its approved drugs for ...

New data from the Phase 3 BRAVE-AA-PEDS trial highlights baricitinib’s strong performance in adolescents facing severe alopecia areata. Incyte (INCY) and Eli Lilly now plan to pursue global approvals ...

New results from Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) showed once-daily, oral baricitinib 4 mg helped ...

Miss USA contestant Mary Sickler was diagnosed with alopecia universalis and lost all hair. The model the first to compete ...

"Lilly and Incyte to seek approval of alopecia JAK inhibitor in children" was originally created and published by ...

Chemotherapy-induced alopecia​ is one of the most common and distressing side effects of chemotherapy. Scalp cooling is a ...

Miss Nevada USA's Mary Sickler, who was diagnosed with alopecia universalis, dazzled onstage at the Miss USA preliminaries ...

Caitlin O'Kane is a New York City journalist who works on the CBS News social media team as a senior manager of content and production. She writes about a variety of topics and produces "The Uplift," ...

A case series of patients with alopecia areata who did not respond to Janus kinase inhibitors shows responses on a second, ...

Alopecia is the medical term for hair loss. Hair loss may occur naturally or it may be related to disease or the use of certain medications. Symptoms of alopecia vary depending on the cause of the ...

Pelage Pharmaceuticals, a clinical-stage regenerative medicine biotech, is advancing PP405, its lead candidate for the ...

Miss USA contestant, Miss Nevada Mary Sickler, who has alopecia, proudly ditched her wig and walked the runway without hair ...